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Increased strength of the aLb2 integrin interaction
with its ligand, ICAM-1, appears to be governed by a
number of factors, including T cell receptor engage-Summary
ment, exposure todiacyl glycerol or phorbol esters (Dus-
tin and Springer, 1991), and other less well-defined sig-The avidity of integrin adhesion receptors for extracel-
nals arising in the context of leukocyte extravasationlular ligands is subject to dynamic regulation by intra-
(Picker and Butcher, 1992; Springer, 1994). At present,cellular programs that have yet to be elucidated. We
the mechanismsthat give rise to enhanced integrin affin-describe here a protein, cytohesin-1, which specifi-
ity are not understood. Cell-surface expression of aLb2cally interacts with the intracellular portion of the inte-
is not increased under conditions that give rise to in-grin b2 chain (CD18). The molecule shows homology
creased avidity (Dustin and Springer, 1991; van Kooykto the yeast SEC7 gene product and bears a pleckstrin
et al., 1989), leading to the hypothesis that either thehomology (PH) domain. Overexpression of either the
aggregation state of the receptors or some conforma-full-length cytohesin-1 or the SEC7 domain induces b2
tional change transmitted across the plasma membrane
integrin–dependent binding of Jurkat cells to ICAM-1,
is responsible for the regulation of adhesion (Diamond
whereas expression of the isolated cytohesin-1 PH
and Springer, 1994; Lub et al., 1995).
domain inhibits T cell receptor–stimulated adhesion.
A few monoclonal antibodies directed against inte-Similar inhibition is not exhibited by PH domains taken
grins have been found to be specific for epitopes that
from other proteins, showing that the interaction is
appear only after their activation pathways have been
specific and that individual PH domains are capable
triggered. Antibodies recognizing activation epitopes
of discriminating between alternative targets. have been described for the platelet fibrinogen receptor
aIIb3 (O’Toole et al., 1990; Shattil et al., 1985) and for
Introduction the leukocyte integrins aLb2 (Dransfield and Hogg, 1989;
Landis et al., 1993; van Kooyk et al., 1991) and aMb2
Integrins, the heterodimeric integral membrane proteins (Diamond and Springer, 1993). The existence of activa-
that mediate cell interaction with matrix and specific cell tion epitopes, while suggestive of a conformational
counterreceptors, are distinctive among cell-surface re- change, is not inconsistent with a mechanism for in-
ceptors for their ability to convey information from the creased adhesion governed by the aggregation state of
cell interior to the exterior. This inverted type of informa- the integrins. Clustering of integrins at the cell surface,
tion flow, often referred to as “inside-out” signaling, is mediated either by constitutive or induced interactions
responsible for the orderly attachment and detachment with cytoskeletal proteins, has been described by sev-
of cells to their surrounding matrix, the adhesion of eral studies (Meijne et al.,1994; Peter and O’Toole, 1995;
platelets to fibrinogen, the coupling of lymphocytes to van Kooyk et al., 1994).
their antigen-presenting cells, and the phagocytosis Mutationalanalyses ofcytoplasmicdomainsequences
of complement-opsonized targets by myelomonocytic have shown that residues in both chains play a role in
phagocytes in the immune system (reviewed by Dia- the regulation of aLb2 activity. A set of three consecutive
mond and Springer, 1994; Hynes, 1992; Sastry and Hor- threonines and a phenylalanine in the b2 cytoplasmic
witz, 1993). The mechanisms by which cytoplasmic sig- domain are required for the constitutive binding to
nals are transmitted across the plasma membrane ICAM-1 of aLb2 expressed in COS cells (Hibbs et al.,
remain unclear, but compelling evidence suggests that 1991; Peter and O’Toole, 1995). Mutants compromising
the intracellular domains of both a (Chan et al., 1992; this interaction retain the ability to respond to phorbol
Filardo and Cheresh, 1994; Kassner and Hemler, 1993; ester stimulation in a more physiological setting, how-
ever, suggesting that other residues may mediate theO’Toole et al., 1991, 1994) and b chains participate in
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contributions of temporally regulated b2 integrin adhe-
siveness (Hibbs et al., 1991).
Of the important topics that remain to be addressed,
the characterization of the cellular components required
for activation-dependent changes in integrin-mediated
adhesiveness is of particular interest. In this study, we
report functional and biochemical analyses of an intra-
cellular protein, cytohesin-1, which appears to be a
regulatory factor for the aLb2 integrin. Cytohesin-1 inter-
acts in yeast with the b2 cytoplasmic domain. Further-
more,cytohesin-1 can be coprecipitated with CD18 from
Jurkat (human T cell leukemia) cells, and it specifically
binds in vitro to a peptide corresponding to the cyto-
plasmic domain of the b2 chain. Overexpression of cy-
tohesin-1 in a T cell leukemia cell line results in constitu-
tive activation of aLb2, and the same phenotype can
be observed following overexpression of an isolated
subdomain of cytohesin-1 that is homologous to the
yeast SEC7 gene product. Overexpression of another
subdomain of cytohesin-1 that is a member of the pleck-
strin homology (PH) domain family results in a specific
inhibition of aLb2-mediated adhesion to ICAM-1.
Results
Molecular Cloning of CD18 Interactors
To identify polypeptides that interact with the b2 cyto-
plasmic domain, we made use of a genetic selection
based on protein–protein interactions in yeast (Gyuris
et al., 1993). A translational fusion cDNA library from
Jurkat cells was introduced into a yeast strain express-
ing a chimeric protein consisting of the complete cyto- Figure 1. Cytohesin-1 Is a Member of a Novel Family of Proteins
plasmic portion of CD18 joined to the DNA-binding por- (A) Subdomain structure of cytohesin-1.
tion of the LexA repressor. Two closely related types of (B) Alignment of cytohesin-1 and the cts18.1 fragment.
cDNAs were found to encode polypeptides that inter-
acted with the CD18 fusion protein in yeast. One of them
corresponded to the previously described B2–1 clone in four other polypeptide sequences to date; its precise
function remains obscure (Shevell et al., 1994, Achstet-(Liu and Pohajdak, 1992). B2–1 transcripts have been
shown to be strongly expressed in natural killer cells ter et al., 1988).
The carboxy-terminal PH domain (Figure 1A; circa 100and cytotoxic T cells (Liu and Pohajdak, 1992), two cell
types that are known to require b2 integrin function amino acids) has been found in several proteins that
participate in signal transduction processes (Haslam etto mediate cellular cytotoxicity efficiently (Dustin and
Springer, 1991). The second sequence, cts18.1, is highly al., 1993; Mayer et al., 1993; Musacchio et al., 1993).
Although the three-dimensional structures of some PHsimilar to B2–1 (88% identical and 9% conserved substi-
tutions at the amino acid level; Figure 1B). By compari- domains have been resolved and candidate ligands
have been described, the precise determinants of PHson with other database entries, we found that both
cDNAs apparently belonged to a larger family of se- domain–binding have not been established. It is uncer-
tain whether all PH domains share a common ligand orquences that currently comprises at least three individ-
ual members (data not shown). whether there are differences between PH domains that
confer target specificity (Ferguson et al., 1994; MaciasAlthough B2–1 was originally proposed to be the hu-
man homolog of the Saccharomyces cerevisiae SEC7 et al., 1994; Tsukada et al., 1994; Yao et al., 1994).
Northern blot analyses performed with transcriptsgene, the dissimilar size, pattern of tissue expression
(Liu and Pohajdak, 1992; data shown below), relatively from several tissues revealed a relatively complex hy-
bridization pattern for both cDNAs. Transcripts of 2.1short region of similarity with SEC7, and effect on cell
adhesion (data shown below) argue that it is a cyto- kb, 4.4 kb, or 9.7 kb in length were detected when a
B2–1 (cytohesin-1) probe was used under stringent hy-plasmic mediator of leukocyte integrin affinity that hap-
pens to share a protein motif with the SEC7 gene. In bridization conditions (Figure 2A). Interestingly, the 2.1
kb mRNA that hybridized to the B2–1 probe appearedwhat follows, we will refer to the protein product of B2–1
as cytohesin-1 (Figure 1). to be highly enriched in spleen or thymus cells (Figure
2A, lanes 7 and 8), while the longer transcripts wereCytohesin-1 contains two distinct polypeptide motifs
found in previously described proteins (Figure 1A). The likewise abundantly although not exclusively present in
tissues of hematopoietic origin.larger of these is the central SEC7 domain, which com-
prises roughly 200 amino acids and has been detected A 2.1 kb transcript that hybridized to cts18.1, on the
Functional Interaction of Cytohesin-1 with CD18
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Figure 2. Northern Blot Analysis of Cytohesin-1 and cts18.1 mRNA
Expression
Northern blots of transcripts from various human tissues were hy-
bridized to probes derived from (A) cytohesin-1, (B) cts18.1, and
(C) b actin (normalization control). mRNAs had been isolated from
peripheral blood leukocytes (lane 1), colon (lane 2), small intestine
(lane 3), ovary (lane 4), testis (lane 5), prostate (lane 6), thymus (lane
7), and spleen (lane 8).
Figure 3. Expression of Cytohesin-1 and Subdomains in Jurkat
Cellsother hand, appeared to be broadly expressed in the
tissues tested (Figure 2B), whereas a transcript of circa (A) Schematic diagram of the constructs used in these experiments.
(B) Western blot analysis of wild-type cytohesin-1 and immunoglob-6.5 kb, which was detected by the same probe, was
ulin-fusion proteins derived from recombinant vaccinia viruses.almost absent from peripheral blood leukocytes, colon,
Wild-type cytohesin-1 was immunoprecipitated and detected byand spleen (Figure 2B, lanes 1, 2, and 8). It remains to be
anti–cytohesin-1 antibody (lane 1). CIg-fusion proteins were precipi-
determined whether these distinct classes of transcripts tated by Protein A–Sepharose and detected by Protein A–peroxi-
are indicative of tissue-specific roles of cytohesin mole- dase (lanes 2–5). Protein bands were visualized by chemilumines-
cules. However, from the present state of analysis, we cence.
Wild-type cytohesin-1 (lane 1), cIg-control (lane 2), cIg–cytohesin-1can conclude that B2–1 transcripts show a prevalence
(lane 3), cIg–cyh-SEC7 (lane 4), and cIg–cyh-PH (lane 5).of expression in cells of the immune system.
(C) Demonstration of cIg–cytohesin-1 overexpression. CIg–cyto-
hesin-1 derived from recombinant vaccinia viruses (lane 1) or cellular
Analysis of Cytohesin-1 Function in Jurkat Cells cytohesin-1 (lane 2) were immunoprecipitated from 107 Jurkat cells,
To test directly whether cytohesin-1 can play a role in each with the help of anti–cytohesin-1 antibody. CIg–cytohesin-1 is
inside-out signaling, a full-length cytohesin-1 sequence overexpressed at least 10-fold; cellular cytohesin-1 present in the
material separated in lane 1 has been competed out by the overex-was isolated by polymerase chain reaction (PCR) from
pressed recombinant protein during immunoprecipitation.a natural killer cell cDNA library and expressed either
(D) Flow cytometric analysis of cytohesin-1 fusion protein expres-as wild-type version (Figure 3B, lane 1) or inserted at
sion in permeabilized Jurkat cells using fluorescein isothiocyanate–
the carboxy-terminus of a fusion protein cassette con- labeled anti-human IgG antibody.
taining the CH2 and CH3 domains of human IgG1 (Figure
3B, lane 3). The resulting chimera (cIg–cytohesin-1) al-
lowed convenient cytoplasmic expression and detec- was used to achieve high level transient expression of
the wild-type and fusion proteins in Jurkat cells, a celltion of fusion protein monomers. Furthermore, cIg-fu-
sion proteins were generated that contained the isolated type that expresses the aLb2 integrin. Recombinant cy-
tohesin-1 and fusion derivatives, which were stronglyPH or SEC7 domains of cytohesin-1, respectively (Figure
3B, lanes 4 and 5). Recombinant vaccinia expression overexpressed as compared to internal protein levels
(Figure 3C; data not shown) could be detected with thetechnology (Kolanus et al.,1993; Romeoand Seed,1991)
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either uninfected Jurkat cells or of infected cells that
expressed a control construct induced a 10–50-fold in-
crease in cell binding to plastic dishes coated with a
soluble form of the extracellular domain of ICAM-1, the
ICAM-1–Receptor globulin (Rg; Figure 4B). Expression
of cytohesin-1 construct or the cIg-fusion protein re-
sulted in constitutive binding of Jurkat cells to ICAM-1,
which was even 2-fold enhanced over anti–T cell re-
ceptor antibody–mediated adhesion of control cells
(Figures 4A and 4B). Cell adhesion to ICAM-1–Rg–
coated plastic could be reversed by blocking antibodies
directed against the aLb2 molecule or ICAM-1 (Figures
4A and 4B).
Because it is often the case that isolated subdomains
of a modular protein can exert an inhibitory effect on
signal transduction in vivo, we examined the effects of
expression of fusion proteins bearing the isolated PH
and SEC7 domains (Figure 4B). In this set of experi-
ments, the immunoglobulin fusion proteins were used
exclusively, because transient expression levels of cy-
tohesin-1 constructs in different cells samples could be
quantitatively compared by flow cytometric detection
of the common immunoglobulin portions (see Figure
3C). We found that expression of the PH domain of
cytohesin-1 consistently blocked the adhesion of stimu-
lated Jurkat cells to ICAM-1–Rg, whereas theexpression
of the SEC7 domain resulted in a constitutive binding
of Jurkat cells to ICAM-1–Rg (Figure 4B).
Because inside-out signaling is thought to affect the
structure and function of integrins and not the number
of expressed molecules, regulatory components that
act at the level of the integrins are not expected to have
any effects on thedensity of integrin surface expression.
As shown in Figure 4C, the surface expression of b2
integrins in Jurkat cells remained unaltered by the intro-
duction of vaccinia-derived cytohesin-1 or subdomain
fusion proteins into these cells.
Further experiments were conducted to investigate
the specificity of cytohesin-1 and subdomain effects on
b2 integrin function. The a4b1 (VLA-4) molecule of the b1
integrin subfamily is known to bind to its ligand VCAM-1
on activated endothelial cells (Osborn et al., 1989). We
used a secreted VCAM-1 immunoglobulin fusion protein
(VCAM-1–Rg; Figure 5) to examine the effects of cy-
tohesin-1 expression on a4b1 function in Jurkat cells.
Jurkat cells were found to bind constitutively to the
Figure 4. Effects of Full-Length Cytohesin-1, PH, and SEC7 Domain
VCAM-1–Rg, and anti–T cell receptor antibody treat-Wild-Type or Fusion Proteins on Jurkat E6 Cell Adhesion to
ment did not cause any further increase in binding. ThisICAM-1–Rg and Effects of the Same Proteins on CD18 Surface
finding indicates that the activities of the a4b1 and aLb2Expression of Jurkat Cells
(A) Cytohesin-1 wild-type or cIg-fusion proteins induce adhesion of molecules are regulated differentially in the same cell
Jurkat cells to ICAM-1–Rg–coated plastic dishes. type. More significantly, none of the cytohesin-1 con-
(B) Cytohesin-1 or SEC7 domain fusion proteins induce constitutive structs had any effect on a4b1-mediated cell binding to
adhesion of Jurkat cells to ICAM-1–Rg. Expression of thePH domain VCAM-1, suggesting a specific role for cytohesin-1 in
fusion protein has a dominant-negative effect on the LFA-1–ICAM-1
aLb2 integrin function (Figure 5).interaction.
Although PH domains have been found in several pro-(C) CD18 surface density of Jurkat cells is not changed by
teins that mediate signal transduction events, their tar-cytohesin-1 and subdomain overexpression.
gets and specificity remain ill defined. We accordingly
asked whether the dominant-negative effect of the cy-
help of either an anti–cytohesin-1 polyclonal antibody tohesin-1 PH domain on integrin function was an effect
(see results below and Experimental Procedures) or with that could be documented with PH domains in general
standard reagents directed against human IgG1 (Figures or was specific to the PH domain of cytohesin-1. Fusion
3B and 3C). proteins bearing the PH domain of vav, a hematopoietic
Consistent with earlier findings (Dustin and Springer, guanine nucleotide exchange factor which is tyrosine-
phosphorylated following T cell activation (Bustelo et1991), treatment with anti–T cell receptor antibody of
Functional Interaction of Cytohesin-1 with CD18
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Figure 5. Cytohesin-1 Fusion Protein Expression Has No Effect on
a4b1 Integrin Binding to VCAM-1
(A) Schematic of the VCAM-1–Rg expression construct.
(B) Adhesion assay (experiments performed in an analogous fashion
to the ones described in Figure 4).
Figure 6. The PH Domain of Cytohesin-1 Specifically Inhibits Jurkatal., 1992; Margolis et al., 1992), the PH domain of the
Cell Adhesion to ICAM-1–Rg
b-adrenergic receptor kinase (bark; Benovic et al.,1986),
(A) Adhesion assay. Various PH domain fusion proteins were testedor the PH domain of the GTPase activating protein of
for their effects on Jurkat binding to ICAM-1, as described in Fig-
the ras protein (ras-GAP; Musacchio et al., 1993) were ure 4.
created and expressed as cIg-fusion proteins in Jurkat (B) Western blot analysis of PH domain fusion protein expression.
cIg–cyh-PH (lane 1), cIg–vav-PH (lane 2), cIg–bark-PH (lane 3), cIg–cells with the aid of recombinant vaccinia viruses (Figure
ras-GAP-PH (lane 4).6B). However, in neither case did expression of the PH
domain have any significant effect on Jurkat cell binding
to ICAM-1–Rg, whereas the expression of the cyto-
hesin-1 PH domain blocked cell adhesion dramatically 3B and 7C). Although the expression of cytohesin-1 was
not found to be limited to hematopoietic cells, it was(Figure 6A).
invariably and abundantly present in lymphoid cells that
contained readily detectable levels (data not shown) ofBiochemical Characterization of the Cytohesin-1
Interaction with CD18 aLb2 integrin, e.g., Jurkat, Hut78, U266, or peripheral
blood lymphocytes. Interestingly, cytohesin-1 proteinWe performed biochemical analyses to investigate the
interaction between cytohesin-1 and CD18 in greater expression appeared to be reduced in certain cell lines
of erythromyeloid or myeloid origin, e.g., K562 or U937.detail. Cytohesin-1 was inserted into a prokaryotic ex-
pression vector that provided an amino-terminal poly- We consequently used the anticytohesin-1 antibody
in coimmunoprecipitation experiments with CD18. Anti-histidin tag.This construct was expressed in Escherichia
coli, and a polyclonal antiserum against purified histag– cytohesin-1 immunoprecipitates from detergent lysates
of Jurkat cells were generated, and the resulting materialcytohesin-1 was generated in rabbits. To obtain a mono-
specific anti–cytohesin-1 antibody, the IgG fraction of was subjected to Western blot analysis. We observed
that CD18 could reproducibly be coprecipitated fromthat serum was affinity-purified on Sepharose columns
that had been covalently derivatized with recombinant these cells by the anticytohesin-1 antibody (Figure 7A,
lane 4) but not by control agent (Figure 7A, lane 3). Mostcytohesin-1 (data not shown). The resulting monospe-
cific anti–cytohesin-1 antibody was employed in immu- significantly, no reactivity was observed when anticy-
tohesin-1 immunoprecipitates were probed with an anti-noprecipitation studies with several hematopoietic or
nonhematopoietic cell lines. Western blot analysis re- CD29 (b1 integrin subunit) antibody (Figure 7B, lane 4).
These data demonstrate that cytohesin-1 and CD18 as-vealed that theantibody specifically precipitated a cellu-
lar protein of circa 47 kDa (Figure 7E). This corresponds sociate specifically in cells of lymphoid origin.
To test in vitro whether the interaction between CD18well to the apparent sizes of the bacterially derived his-
tag–cytohesin-1 fusion protein or full-length cytohesin-1 and cytohesin-1 was direct, synthetic peptides that cor-
respond to the cytoplasmic domains of CD18 or CD29expressed by recombinant vaccinia viruses (see Figures
Cell
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(sequences are given in Experimental Procedures) were
covalently attached to Sepharose beads, hereafter
termed CD18cyt–Sepharose or CD29cyt–Sepharose, re-
spectively. Purified histag–cytohesin-1, which bears a
fusion vector–derived amino-terminal consensus se-
quence for a protein kinase A phosphorylation site, was
labeled with 32P by the purified catalytic subunit of
protein kinase A for convenient in vitro detection. Subse-
quent binding studies demonstrated that histag–cyto-
hesin-1 specifically bound to the CD18cyt–Sepharose
(Figure 7C, lane 5), whereas no interaction was detected
with either CD29cyt–Sepharose, a mixture of unrelated
control peptides, or Sepharose beads alone (Figure 7C,
lanes 2–4). These data suggest a direct and specific
molecular interaction between CD18 and cytohesin-1.
To evaluate the affinity of cytohesin-1 for the cyto-
plasmic domain of CD18, quantitative binding assays
were performed. Figure 7D shows that binding of cy-
tohesin-1 to CD18cyt–Sepharose was saturable with a
half-maximal association at a concentration of circa 2.5
mM histag–cytohesin-1, whereas only insignificant and
unsaturable binding to CD29cyt–Sepharose at very high
protein concentrations was observed. Furthermore, his-
tag versions of the CD18 or the CD29 cytoplasmic do-
mains were also expressed in E. coli, and binding of a
glutathione S-transferase fusion protein of cytohesin-1
to these recombinant proteins was assayed (data not
shown). The results obtained were very similar to the
ones described above. Half-maximal binding of gluta-
thione S-transferase–cytohesin-1 to histag-CD18 was
achieved at a concentration of 5 mM glutathione S-trans-
ferase–cytohesin-1, whereas no binding to histag-CD29
was detected.
Specificity of Cytohesin-1 and Subdomain
Interactions in Yeast
To define better thesite of interaction between the CD18
cytoplasmic domain and cytohesin-1, we created yeast
expression constructs bearing the isolatedPH and SEC7
domains and tested their interaction with the CD18 cyto-Figure 7. Biochemical Analysis of the Cytohesin-1–CD18 Interac-
plasmic domain in the yeast two-hybrid system. Wetionand Native Cytohesin-1 Protein Expression in Various Cell Types
found that the SEC7 domain reproducibly interacted(A) Coimmunoprecipitation of CD18 with cytohesin-1 from Jurkat
with CD18, whereas no interaction of CD18 could becells.
Starting with whole detergent lysates from Jurkat cells (lane 1), detected with the PH domain.
immunoprecipitations were performed with rabbit anti-CD18 anti- The ability of the cytohesin-1 to associate with other
body (lane 2), rabbit serum (control, lane 3), and anti–cytohesin-1 surface receptor cytoplasmic domains was also ex-
antibody (lane 4). Monoclonal antibody MEM-48 was used to detect
plored with the aid of the yeast system. The alternativeCD18 specifically in the immunoprecipitates. CD18 expression is
targets included thecytoplasmic domainsof CD29,CD2,detected as a cluster of bands migrating between 100 and 120 kDa.
CD4, CD8, or the full-length syk, ZAP-70, lck, and fynNo bands were detected when replicas of the blot were stained with
isotype-matched control monoclonal antibody IN-05 (mouse IgG1 protein-tyrosine kinases. No interaction with any of
to insulin).
(B) Cytohesin-1 does not interact with CD29 in Jurkat cells. Analo-
gous experiment to the one shown in Figure 7A.
Total lysate (lane 1), anti-CD29 monoclonal antibody MEM-101A (D) Affinity of histag–cytohesin-1 for CD18 or CD29 cytoplasmic
(lane 2), rabbit control serum (lane 3), anti–cytohesin-1 antibody domain peptides coupled to Sepharose. Quantitative analysis was
(lane 4). Monoclonal antibody MEM-101A was also used to detect determined as described in Experimental Procedures. Background
CD29 on the Western blot and is therefore visible as high molecular binding to the matrix had been subtracted from each sample before
mass material in lane 2 (nonreducing conditions). plotting counts versus input protein concentration.
(C) In vitro interaction of histag–cytohesin-1 with CD18cyt–Sepha- (E) Immunoprecipitation analysis. Immunoblot of homogenate su-
rose. The binding of purified 32P-labeled histag–cytohesin-1 (lane 1, pernatants from different cell lines using the anticytohesin antibody
input material) was measured to resin alone (lane 2), to a mixture as precipitating and detecting antibody. As indicated by the arrow,
of two unrelated peptides (lane 3), to a CD29 peptide (lane 4), and the antibody identifies cytohesin-1 as a 47 kDa cellular protein. The
to a CD18 peptide (lane 5), each peptide covalently linked to Sepha- lower molecular mass protein band present in the PBL (peripheral
rose. The protein band that corresponds to histag-cytohesin is indi- blood lymphocytes) lane is an apparent degradation product of
cated by the asterisk. cytohesin-1.
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these molecules could be detected, demonstrating that thus lead to receptor aggregation. The model implies a
relatively complex combination of inside-out and out-the association of cytohesin-1 with the b2 integrin sub-
unit is highly specific. These results are fully consistent side-in signaling events in order to achieve a fully adhe-
sive phenotype of integrins. Since the evidence for func-with the data described above: the b1 integrin (CD29)
cytoplasmic domain interacts neither with cytohesin-1 tionally important modifications (e.g., phosphorylation)
of the intracellular domains of b2 integrins remains poorin yeast, nor in Jurkat cells, nor in vitro, and, as can
be expected from these results, b1 integrin function (Hibbs et al., 1991), other cytoplasmic regulatory ele-
ments, which have yet to be defined, have consequentlyappears not to be affected by cytohesin-1 or subdomain
overexpression in Jurkat cells. been postulated to be required in this scheme (Lub et
al., 1995).
Cytohesin-1 appears to be a likely candidate for such
Discussion a functional adaptor. Our findings indicate that direct
molecular interactions between cytohesin-1 and CD18
The avidity of b2 integrins for cellular counterreceptors are involved in triggering aLb2-mediated cellular adhe-
is controlled by intracellular mechanisms that are not sion. Most importantly, cytohesin-1 regulates the inter-
well understood, despite the large body of information action between aLb2 and ICAM-1 in a physiologically
gathered to date. Our results suggest that cytohesin-1 relevant setting, i.e., in the context of cells that are capa-
interacts functionally and physically with the cytoplas- ble of switching between high and low avidity states
mic domain of the integrin b2 chain in Jurkat cells and of b2 integrins in response to external stimuli. Further
plays a role in the regulation of aLb2 integrin–mediated studies will have to address the question of whether
adhesion. Cytohesin-1 does not show homology to pro- this regulation requires functional cooperation of cy-
tein domains with known enzymatic activity; rather, its tohesin-1 with, for example, known cytoskeletalproteins
modular structure implies that it may be an adaptor that may be involved in the control of integrin activity,
protein that couples b2 integrins to upstream signaling or whether this molecule links CD18 to other elements
events. of the signaling machinery that are yet unknown.
How is inside-out signaling of b2 integrins regulated? Although it is well documented that the adhesive func-
Two major lines of reasoning, which are not mutually tion of most members of the integrin family can be
exclusive, have attempted to explain the observed phe- activated in a phenotypically similar fashion (see Intro-
nomena (reviewed by Diamond and Springer, 1994). One duction and references therein), it is unclear whether
of the proposed mechanisms involves regulated interac- common or independent cellular pathways underlie this
tions of integrins with the cytoskeleton. Such processes apparent uniformity. We have investigated the influence
could facilitate cell-surface clustering of the adhesion of cytohesin-1 overexpression on b2 and b1 integrins
receptors and thus regulate their avidity rather than their that were expressed on the same cell type and found
affinity for extracellular ligands. Previous studies have that cytohesin-1 appears to regulate aLb2 function spe-
reported the colocalization or in vitro association of cifically. Furthermore, cytohesin-1 associates exclu-
CD18 with cytoskeletal components, e.g., with a actinin sively with the cytoplasmic domain of the b2 subunit
(Pavalko and LaRoche, 1993), filamin (Sharma et al., when assayed in Jurkat cells, in yeast, or in vitro. How-
1995), or talin (Burn et al., 1988). Especially the interac- ever, we cannot completely exclude the possibility that
tion of CD18 with a actinin has been demonstrated to members of the b2 subfamily might share proximal regu-
be direct and appears to be upregulated in activated latory components with other integrins. Interestingly,
neutrophils (Pavalko and LaRoche, 1993). However, the two proteins have recently been described that couple
roles of these interactions in inside-out signaling events to the cytoplasmic domains of b1 (Hannigan et al., 1996)
remain controversial, mainly because of the fact that or b3 integrin (Shattil et al., 1995) subunits, respectively.
independent studies obtained contradictory results Those molecules are related neither to each other nor to
about integrin activation when inhibitors of actin-cyto- cytohesin-1, suggesting that although the cytoplasmic
skeleton rearrangement were employed (Diamond and domains of integrin b subunits are quite similar, they
Springer, 1994; Peter and O’Toole, 1995). may still couple to distinct functional pathways.
There is evidence, on the other hand, that specific Our results suggest that cytohesin-1 contains subdo-
epitopes can be detected in the contextof integrin extra- mains that represent functional modules. One of them,
cellular domains only after cellular activation events the carboxy-terminal PH domain, dramatically interferes
have been triggered. The appearance of at least some of with b2 integrin function but does not bind to CD18
theseepitopes may best beexplained by conformational in yeast. Although the precise roles of PH domains in
changes within individual integrin heterodimers. signaling are not understood, present data suggest that
In an attempt to integrate these views, a two-step PH domains may, like SH2 and SH3 domains, mediate
mechanism for b2 integrin activation (Lub et al., 1995; specific associations of intracellular signal transduction
Peter and O’Toole, 1995) was proposed. In this hypo- elements under the influence of regulatory input origi-
thetical scenario, the formation of signal-dependent nating from cell-surface receptors (Pawson, 1995). Evi-
neo-epitopeswithin the extracellular domains of integrin dence is persuasive that compromise of PH domain
molecules results in cell adhesion of intermediate avid- function of Bruton’s tyrosine kinase underlies the dys-
ity. Such proposed weak interactions of integrins with regulation of B cell ontogeny that is associated with the
extracellular ligands may in turn lead to “postreceptor” murine X-linked immunodeficiency syndrome (Rawlings
events that could facilitate the association of integrin et al., 1993). Based on the observation that PH domains
appear to be present in cytoplasmic proteins that arecytoplasmic domains with cytoskeletal elements and
Cell
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(ras-GAP-PH). All PCR products were inserted into pcIgTKG, andoften recruited to the plasma membrane in the course
sequence identity was confirmed by double-stranded sequencing.of signal transduction events, it has been speculated
For expression in prokaryotes, the cytohesin-1 sequence was in-that PH domains may contribute to the localization of
serted into the SalI and NotI sites of a bacterial expression vector
proteins to the plasma membrane (Pawson, 1995). The bearing an amino-terminal polyhistidin-tag (pT7HXBflu; T. Gulick,
finding that inositol phosphates bind to some PH do- unpublished data).
Secreted receptor-globulin fusion proteins of the ICAM-1 ormains in vitro is consistent with this hypothesis (Harlan
VCAM-1 extracellular domainswere created in an analogous fashionet al., 1994, Lemmon et al., 1995). With regard to these
to the ones described in Walz et al. (1990).results, it seems intriguing that the PH domain of cy-
tohesin-1, while not interacting with the transmembrane
Cell Lines and Antibodies
protein CD18 directly, acts as a specific dominant-nega- 293, CV-1, HT29, HeLa, HepG2, HUT78, Jurkat E6, K562, U266BL,
tive inhibitor of aLb2 function. It presumably serves to and U937 cells were obtained from American Type Culture Collec-
couple elements of the inside-out signaling pathway to tion. Anti-CD11a and anti-CD18 antibodies MEM-30 and MEM-48
(Bazil et al., 1990) and anti-CD29 antibody MEM101A were giftsthe integrins. Future studies, which will have to address
from Dr. V. Horejsi (Institute of Molecular Genetics, Prague). Rabbitthe ligand specificity of the cytohesin-1 PH domain, may
polyclonal antibody to CD18 was a gift from G. Boonen (La Jollahelp to answer the question of whether the PH domain
Cancer Research Foundation). Anti-CD54 (ICAM-1) antibody (Immu-
aids in the recruitment of cytohesin-1 to the plasma notech) was purchased. A rabbit antiserum against bacterially de-
membrane. rived histag–cytohesin-1 was generated by Eurogentec.
In contrast, the finding that the SEC7 domain alone
Yeast Interactor Screeningcan act as a positive regulator of aLb2 integrin function,
The genetic screening procedure for the isolation of protein inter-however not as effectively as full-length cytohesin-1,
actors with the complete CD18 cytoplasmic domain (KALIHLSDLREsuggests that this domain may require additional input,
YRRFEKEKLKSQWNNDNPLFKSATTTVMNPKFAES) was essentially
such as a steric transition or membrane recruitment, performed as described previously (Gyuris et al., 1993). The
to mediate its full activity. An attractive hypothesis at plex202–CD18 expression vector was transformed into yeast strain
present is that the PH motif provides this additional EGY48 bearing the JK103 lacZ reporter plasmid. This “bait” strain
was transformed with a yeast expression library cDNA derived frominput as a result of its interaction with other elements
Jurkat mRNA yielding circa 1 3 106 independent yeast recombi-of the signal transduction machinery.
nants. Copies (circa 10–20) of the yeast library pool were subjectedTaken together, our results provide functional and
to selection and screening as described; cDNAs from positive yeast
biochemical evidence that we have identified an impor- clones were isolated and transformed into E. coli KC8 (Gyuris et al.,
tant novel component of an intracellular signal transduc- 1993), from which they were amplified for further analysis.
tion pathway that specifically regulates the adhesive
function of b2 integrins in lymphocytes. Northern Blot Analysis
Commercially available Northern blots (Clontech) were hybridized
according to instructions of the manufacturer, with DNA probesExperimental Procedures
derived from cytohesin-1 or cts18.1 that had been labeled with 32P
prior to hybridization.Construction of Expression Plasmids
PCR primers bearing the sequences CGC GGG ACG CGT GCT CTG
Expression of Histag–Cytohesin-1 in E. coliATC CAC CTG AGC and CGC GGG GCG GCC GCT TTA ACT CTC
The prokaryotic fusion protein encoded by histag–cytohesin-1 ex-AGC AAA CTT GGG were used to amplify the sequence of the CD18
pression plasmid was purified from E. coli BL21lysS, according tocytoplasmic domain from a CD18 expression plasmid (Simmons et
standard procedures (Qiagen). Protein yields were between 2–25al., 1988). The resulting product was inserted into a derivative of
mg/l culture.the yeast expression vector plex202 (Gyuris et al., 1993). CH2 and
CH3 domain segments from a human IgG1 cDNA, provided with
Coimmunoprecipitation Analysisoptimal eukaryotic translation initiation sequences, were amplified
Immunoprecipitation and immunoblotting was done essentially asby PCR and inserted into a derivative of the vaccinia expression
described previously (Bohuslav et al., 1995). Briefly, 2 3 107 cellsvector pTKG (Romeo and Seed, 1991). The resulting expression
were lysed in 1 ml of ice-cold lysis buffer containing 20 mM Trisvector will hereafter be termed pcIgTKG. PCR primers bearing the
(pH 8.2), 140 mM NaCl, 1% Brij-58 (Pierce), 5 mM iodoacetamide,sequences CGC GGG GAA TTC GCC ACC ATG GAG GAG GAC
aprotinin and leupeptin (both 10 mg/ml), 1 mM phenylmethylsulfonylGAC AGC TAC GTT CCC and CGC GGG GCG GCC GCT TTA GTG
fluoride, 0.1 mM quercetin, 0.1 mM N-tosyl-L-phenylalanine chloro-TCG CTT CGT GGA GGA GAC CTT were used to amplify a full-
methyl ketone, 0.1 mM Na-p-tosyl-L-lysine chloromethyl ketone, 0.1length cytohesin-1 cDNA corresponding to the B2–1 cDNA from
mM N-CBZ-L-phenylalanine chloromethyl ketone (all from Sigma),a natural killer expression library. The cytohesin-1 sequence was
for 30 min. After removal of insoluble material by centrifugation, thesubcloned into the pcIgTKG cassette or, for wild-type protein ex-
lysates were subjected to immunoprecipitation by the solid-phasepression, directly into the pTKG expression vector. Subdomain con-
immunoisolation technique on 96 well plastic plates.structs weregenerated by PCRfrom expression plasmids or expres-
Immunoprecipitated material was subsequentlydetected by stan-sion libraries using the following primers: GCG GGG ACG CGT ACC
dard Western blotting techniques.ATG GCT AAT GAA ATT GAA AAC CTG and GCG GGG GCG GCC
GCT TTA GAA AGT GTG AGT GAG GTC ATT CCC (cyh-SEC7)
CGC GGG ACG CGT ACC ATG GGT TTC AAT CCA GAC CGA In Vitro Interaction Assay
Purified histag–cytohesin-1 was labeled in vitro with 32P by the cata-GAA GGC TGG and GG GCG GGG GCG GCC GCT TTA GAA AGG
GTC CCT GCT GAT (cyh-PH) lytic subunit of protein kinase A (Boehringer Mannheim). Labeled
cytohesin-1 was incubated either with 46 mer peptides correspond-GCG GGG ACG CGT ACC ATG GAC TAC GCC CTG GGC AAG
GAC and GCG GGG GCG GCC GCT TTA CTG CTG GGC CTC GCG ing to the CD18 (see above) or CD29 (KLLMIIHDRREFAKFEKEK-
MNAKWDTGENPIYKSAVTTVVNPKYEG K) cytoplasmic domains, re-GTA GGC GTC (bark-PH)
GCG GGG ACG CGT ACC ATG GTT CTG GCT CAC TAT GGC spectively, which had been covalently linked to Sepharose-4B
according to standard protocols (Pharmacia), or it was incubatedCGG and GGG CGG CGG CCG CTT TAC GGA TAG ATG TTG GAG
ATG (vav-PH) with a mixture of unrelated control peptides (peptide a, GDTDDLSN
FGL-COOH; peptide b, GSYAGAVVNDL-COOH) linked to the sameGCG GGG ACG CGT ACC ATG GTT GAT GCC TTT TAT AAA AAC
and GGG CGG GGG CGG CCG CTT TAA CTT TTC CGT AAA TTG type of resin (donation of Dr. M. Famulok, Genzentrum Mu¨nchen)
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for 1 hr at 258C in buffer containing 50 mM Tris–HCl (pH 7.5), 80 Chan, B.M., Kassner, P.D., Schiro, J.A., Byers, H.R., Kupper, T.S.,
and Hemler, M.E. (1992). Distinct cellular functions mediated bymM NaCl, 1 mM phenylmethylsulfonyl fluoride, and 0.05% NP-40.
The samples were subsequently washed with 100 vol of incubation different VLA integrin a subunit cytoplasmic domains. Cell 68, 1051–
1060.buffer, boiled in SDS sample buffer (Ausubel et al., 1987), and elec-
trophoresed through 8% SDS–polyacrylamide gels. Gels were sub- Chen, Y.P., O’Toole, T.E., Shipley, T., Forsyth, J., LaFlamme, S.E.,
sequently dried and autoradiographed. For quantitative analysis, Yamada, K.M., Shattil, S.J., and Ginsberg, M.H. (1994). “Inside-out”
histag–cytohesin-1 was radiolabeled to a specific activity of 0.5 mCi/ signal transduction inhibited by isolated integrin cytoplasmic do-
mg, separated from free label by gel filtration, diluted with unlabeled mains. J. Biol. Chem. 269, 18307–18310.
protein, and employed in binding assays as described above.
Diamond, M.S., and Springer, T.A. (1993). A subpopulation of Mac-
1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-Eukaryotic Expression and Adhesion Assay
1 and fibrinogen. J. Cell Biol. 120, 54556.Vaccinia expression constructs were recombined with wild-type
Diamond, M.S., and Springer, T.A. (1994). The dynamic regulationvaccinia virus (WR strain) in CV-1 cells, recombinant plaques were
of integrin adhesiveness. Curr. Biol. 4, 506–517.purified, and high titer virus stocks were generated as described
(Romeo and Seed, 1991). ICAM-1–Rg or VCAM-1–Rg fusion proteins Dransfield, I., and Hogg, N. (1989). Regulated expression of Mg21
were expressed in COS cells, purified from culture supernatants by binding epitope on leukocyte integrin a subunits. EMBO J. 8, 3759–
Protein A–Sepharose, eluted, resuspended in phosphate-buffered 3765.
saline, and subsequently coated onto Falcon 1008 dishes as de-
Dustin, M.L., and Springer, T.A. (1991). Role of lymphocyte adhesion
scribed (Walz et al., 1990). 2 3 106 Jurkat cells were infected with
receptors in transient interactions and cell locomotion. Annu. Rev.
recombinant viruses and incubated for 4 hr at 378C. After centrifuga-
Immunol. 9, 27–66.
tion, cells were resuspended in RPMI medium and incubated for 5
Ferguson, K.M., Lemmon, M.A., Schlessinger, J., and Sigler, P.B.min at 378C with or without the addition of 2 mg/ml of purified OKT3
(1994). Crystal structure at 2.2 A˚ resolution of the pleckstrin homol-antibody. Cells were subsequently allowed to adhere to ICAM-1–Rg
ogy domain from human dynamin. Cell 79, 199–209.or VCAM-1–Rg–coated dishes at 378C for 10 min, and the bound
fraction was determined with the aid of an ocular reticle. Filardo, E.J., and Cheresh, D.A. (1994). A b turn in the cytoplasmic
tail of the integrin av subunit influences conformation and ligand
Acknowledgments binding of avb3. J. Biol. Chem. 269, 4641–4647.
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